Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- Check5 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous revision v3.4.2 from the history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedVisual/layout updates to the Record History page; core study data and identifiers appear unchanged.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry v3.4.2 was added to the history and older funding notices were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedThe page now displays a government funding notice banner with links to cc.nih.gov and opm.gov. The record history shows Revision: v3.4.1 added and Revision: v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedUI updates include enabling the glossary display, color-coded highlighting of changes (green for additions and red for deletions), and a revision label updated to v3.4.0, while removing older FEAR Act labeling.SummaryDifference0.9%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.